Clinical Trial Update: Using Santyl or Bacitracin on Second Degree Burns [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating Santyl (collagenase) versus bacitracin for partial-thickness burns has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Burns

Drugs mentioned

• Bacitracin (bacitracin)
• Santyl (collagenase)

Snippet

Sponsor: Healthpoint | Conditions: Burn, Partial Thickness | Phase 4 | Status: WITHDRAWN